Chemical Engineering Journal · 2021 · 32 citations · 28 references
Life SciencesCancer BiologyChemistryCancer ImmunologyImmunotherapyTumor ImmunologyCell-nanoparticle InteractionsLigand BindingMacromolecular AssemblyNanomedicineSelf-assembly Of NanomaterialsTheranostic NanoparticlesCancer Immunotherapy NanoparticlesNanocluster ChemistryPeptide NanoparticlesPeptide Self-assemblySelf-assembling Peptide NanomaterialsTumor Targeting LigandsTumor-targeted LigandsTumor-targeting Peptides
28
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al. · Nature · 2014 · 5.3K citations
Medicine, Immunology, Oncology +16
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.9K citations · Full text
Medicine, Immunology, Oncology +17
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin et al. · New England Journal of Medicine · 2016 · 3.2K citations · Full text
Medicine, Immunology, Oncology +17
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger, Riyue Bao, Thomas F. Gajewski · Nature · 2015 · 2.8K citations
Medicine, Cancer Biology, Oncology +10
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang et al. · Cancer Immunology Immunotherapy · 2011 · 777 citations · Full text
Medicine, Immunology, Oncology +10